Unable to load price data. Sorry.


Abaxis, Inc. (NASDAQ:ABAX.DL)

CAPS Rating: No stars

The Company develops, manufactures and markets portable blood analysis systems for use in any veterinary or human patient-care setting to provide clinicians with rapid blood constituent measurements.

Unable to load market data for this Ticker. Sorry.



This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

0 Outperform
0 Underperform

All-Star Players

0 Outperform
0 Underperform

Wall Street

0 Outperform
0 Underperform

Top NASDAQ:ABAX.DL Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

longshort87 (< 20)
Submitted January 06, 2008

Abaxis has a solid niche in the veterinary point-of-care diagnostics business augmented by an open-ended growth opportunity in human point-of-care diagnostics thanks to its unique Piccolo Xpress machine. The business model is classic razor-and-blade,… More

brent2112 (< 20)
Submitted January 12, 2007

Abaxis has seen its glory days. I've watched this stock climb from $4-5 per share up to over $20. Unless they come up with something new, they will be relying on their reagent discs to supply income.



  • Sector:
  • Industry:
  • Tags:

Recent Community Commentary

Read the most recent pitches from players about ABAX.DL.

No one has written a Pitch for ABAX.DL stock yet. Tell us why you think ABAX.DL will outperform or underperform against the market.


Find the members with the highest scoring picks in ABAX.DL.

No players have picked ABAX.DL yet. Tell us why you think ABAX.DL will outperform or underperform against the market.

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for ABAX.DL.